H.G.M. Leufkens

2.7k total citations · 1 hit paper
29 papers, 2.0k citations indexed

About

H.G.M. Leufkens is a scholar working on Surgery, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, H.G.M. Leufkens has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Psychiatry and Mental health and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in H.G.M. Leufkens's work include Bone health and osteoporosis research (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Schizophrenia research and treatment (4 papers). H.G.M. Leufkens is often cited by papers focused on Bone health and osteoporosis research (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Schizophrenia research and treatment (4 papers). H.G.M. Leufkens collaborates with scholars based in Netherlands, United Kingdom and New Zealand. H.G.M. Leufkens's co-authors include Tjeerd van Staa, Cyrus Cooper, Elaine Dennison, Toine C. G. Egberts, Patrick C. Souverein, BR Walker, Anick Bérard, Lucien Abenhaim, Paul D. van der Linden and Miriam Sturkenboom and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Bone.

In The Last Decade

H.G.M. Leufkens

29 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology of fractures in England and Wales

2001 825 citations Tjeerd van Staa, Elaine Dennison et al. Bone profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H.G.M. Leufkens Netherlands	13	845	810	360	257	245	29	2.0k
H.G.M. Leufkens Netherlands	19	979 1.2×	454 0.6×	474 1.3×	463 1.8×	511 2.1×	28	2.9k
C Cooper United States	5	1.7k 2.0×	705 0.9×	219 0.6×	572 2.2×	450 1.8×	8	2.4k
S. A. Jamal Canada	18	1.7k 2.0×	971 1.2×	291 0.8×	530 2.1×	320 1.3×	23	2.4k
Nitin Kapoor India	22	485 0.6×	336 0.4×	235 0.7×	241 0.9×	301 1.2×	250	1.9k
Jin‐Su Choi South Korea	29	384 0.5×	564 0.7×	456 1.3×	425 1.7×	572 2.3×	111	2.8k
A Tosteson United States	8	2.0k 2.4×	967 1.2×	298 0.8×	663 2.6×	514 2.1×	10	2.7k
Juraj Payer Slovakia	20	482 0.6×	315 0.4×	294 0.8×	250 1.0×	293 1.2×	132	1.9k
Patrícia Caetano Canada	21	873 1.0×	745 0.9×	271 0.8×	230 0.9×	128 0.5×	32	2.0k
Sonia Jean Canada	21	738 0.9×	690 0.9×	212 0.6×	264 1.0×	145 0.6×	51	1.6k
Margaret L. Gourlay United States	24	1.2k 1.4×	490 0.6×	116 0.3×	411 1.6×	382 1.6×	48	1.9k

Countries citing papers authored by H.G.M. Leufkens

Since Specialization

Citations

This map shows the geographic impact of H.G.M. Leufkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.G.M. Leufkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.G.M. Leufkens more than expected).

Fields of papers citing papers by H.G.M. Leufkens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.G.M. Leufkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.G.M. Leufkens. The network helps show where H.G.M. Leufkens may publish in the future.

Co-authorship network of co-authors of H.G.M. Leufkens

This figure shows the co-authorship network connecting the top 25 collaborators of H.G.M. Leufkens. A scholar is included among the top collaborators of H.G.M. Leufkens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.G.M. Leufkens. H.G.M. Leufkens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

d’Andon, Anne, et al.. (2016). Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries. Annals of Oncology. 27(9). 1768–1775. 44 indexed citations

Koeter, Maarten W.J., et al.. (2015). Net gain analysis, an addition to responder analysis – The case of antipsychotic treatment of acute mania. Regulatory Toxicology and Pharmacology. 73(1). 227–231. 1 indexed citations

Koeter, Maarten W.J., et al.. (2015). Placebo response in antipsychotic trials of patients with acute mania. European Neuropsychopharmacology. 25(7). 1018–1026. 5 indexed citations

Boer, A. de, et al.. (2013). Selection of oncology medicines in low- and middle-income countries. Annals of Oncology. 25(1). 270–276. 27 indexed citations

Souverein, Patrick C., et al.. (2012). Reimbursement Restriction and Moderate Decrease in Benzodiazepine Use in General Practice. The Annals of Family Medicine. 10(1). 42–49. 34 indexed citations

Herings, Ron M. C., et al.. (2005). Antipsychotic-induced Extrapyramidal Syndromes in Psychiatric Practice: A Case-control Study. Pharmacy World & Science. 27(4). 285–289. 6 indexed citations

Souverein, Patrick C., Anick Bérard, Tjeerd van Staa, et al.. (2004). Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study. Heart. 90(8). 859–865. 368 indexed citations

Souverein, Patrick C., Tjeerd van Staa, Toine C. G. Egberts, et al.. (2003). Use of α‐blockers and the risk of hip/femur fractures. Journal of Internal Medicine. 254(6). 548–554. 45 indexed citations

Buurma, Henk, et al.. (2003). Incidence and determinants of antidepressant drug use in migraine patients. International Clinical Psychopharmacology. 18(6). 331–339. 4 indexed citations

10.

Stolker, Joost J., et al.. (2003). [Seclusion of admitted psychotic patients: later in the case of antipsychotic use and also possibly less often].. PubMed. 147(12). 557–61. 2 indexed citations

11.

Sturkenboom, Miriam, Paul D. van der Linden, RM Herings, et al.. (2003). Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. European Journal of Cancer. 39(1). 98–105. 31 indexed citations

12.

Staa, Tjeerd van, Tjeerd van Staa, Tjeerd van Staa, H.G.M. Leufkens, & Cyrus Cooper. (2002). Does a Fracture at One Site Predict Later Fractures at Other Sites? A British Cohort Study. Osteoporosis International. 13(8). 624–629. 232 indexed citations

13.

Leufkens, H.G.M., et al.. (2002). Variability in abciximab (ReoPro®) prescribing: evidence based or budget driven?. Pharmacoepidemiology and Drug Safety. 11(2). 135–141. 2 indexed citations

14.

Movig, Kris L. L., H.G.M. Leufkens, A.W. Lenderink, & Toine C. G. Egberts. (2002). Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. European Journal of Clinical Pharmacology. 58(2). 143–148. 43 indexed citations

15.

Buurma, Henk, et al.. (2002). Incidence and determinants of migraine prophylactic medication in the Netherlands. European Journal of Clinical Pharmacology. 58(2). 149–155. 11 indexed citations

16.

Staa, Tjeerd van, Elaine Dennison, H.G.M. Leufkens, & Cyrus Cooper. (2001). Epidemiology of fractures in England and Wales. Bone. 29(6). 517–522. 825 indexed citations breakdown →

17.

Linden, Paul D. van der, et al.. (2001). Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands.. Pharmacy World & Science. 23(3). 89–92. 20 indexed citations

18.

Klungel, Olaf H., et al.. (2001). Costs and effects of combining stenting and abciximab (ReoPro®) in daily practice. International Journal of Cardiology. 77(2-3). 299–303. 4 indexed citations

19.

Staa, Tjeerd van, et al.. (2000). The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiology and Drug Safety. 9(5). 359–366. 135 indexed citations

20.

Staa, Tjeerd van, H.G.M. Leufkens, Lucien Abenhaim, & Cyrus Cooper. (1998). Postmarketing Surveillance of the Safety of Cyclic Etidronate. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(5). 1121–1128. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact